Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY:BSX)

90.03 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Jan 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
22 23 Next >
News headline image
Preview: Boston Scientific's Earnings ↗
 
Via Benzinga
News headline image
Boston Scientific Corporation Should Continue Uptrend & Remain Supported ↗
Boston Scientific Corporation develops, manufactures & markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg & Cardiovascular segments. 
Via Talk Markets
News headline image
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism? ↗
An analyst sees the Satya Nadella-led company's earnings to be the key barometer for AI spending. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Looking Into Boston Scientific's Recent Short Interest ↗
 
Via Benzinga
News headline image
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst ↗
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth. 
Via Benzinga
News headline image
Chart Of The Day: Boston Scientific - Revenue Growth Potential ↗
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. 
Via Talk Markets
News headline image
Palo Alto Networks, Nvidia, And 2 Other Stocks Insiders Are Selling ↗
The Nasdaq 100 closed slightly lower on Tuesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
News headline image
Demystifying Boston Scientific: Insights From 10 Analyst Reviews ↗
 
Via Benzinga
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Why Axonics Stock Soared Today ↗
The medical device maker agreed to be acquired by Boston Scientific. 
Via The Motley Fool
News headline image
7 Healthcare Stocks Taking Medicine to the Next Level ↗
With advances in technology potentially able to improve the human condition, these are the compelling healthcare stocks to consider. 
Via InvestorPlace
News headline image
Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review ↗
The major indexes and leading stocks rebounded. Bitcoin ETFs fell in their debut. 
Via Investor's Business Daily
Topics ETFs
News headline image
5 A-Rated Stocks to Buy ASAP in 2024 ↗
2024 is ushering in a new era for investors, and these top-notch, A-rated stocks to buy are likely to be market winners. Here's why. 
Via InvestorPlace
News headline image
Health Care Company Boston Scientific Announces Acquisition of Axonics ↗
 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years ↗
 
Via Benzinga
News headline image
Boston Scientific Stock: A Deep Dive Into Analyst Perspectives (8 Ratings) ↗
 
Via Benzinga
News headline image
10 Top Stocks With a Strong Buy Rating Right Now ↗
Wall Street is highly bullish on these strong buy stocks, even as financial markets face an uncertain year. Here are the names to watch. 
Via InvestorPlace
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
NYSE:BSX may be ready to breakout. ↗
BOSTON SCIENTIFIC CORP (NYSE:BSX) Reveals Intriguing Technical Aspects. Here's What You Need to Know. 
Via Chartmill
News headline image
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today ↗
 
Via Benzinga
News headline image
(BSX) - Analyzing Boston Scientific's Short Interest ↗
 
Via Benzinga
News headline image
Why Is Axonics (AXNX) Stock Up 20% Today? ↗
Axonics stock is rising higher on Monday as investors react to a $71 per share cash offer for AXNX stock from Boston Scientific. 
Via InvestorPlace
News headline image
Why Is Bladder Disorder Focused Axonics Stock Trading Higher Today? ↗
Boston Scientific Corporation (NYSE: BSX) has agreed to acquire Axonics Inc (NASDAQ: AXNX) for $7 
Via Benzinga
News headline image
J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value ↗
The year's biggest medical conference kicked off with a melee of buyout news. 
Via Investor's Business Daily
News headline image
Axonics Announces Definitive Agreement to be Acquired by Boston Scientific
From Axonics, Inc.
Via Business Wire
News headline image
Stock Picks 2024: 7 Trailblazers Using AI to Revolutionize Their Industries ↗
Although AI-related stock picks for 2024 may be centered on tech firms, the innovation itself achieves broad relevance. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Why Medical Devices Behemoth Boston Scientific Shares Are Rising Friday ↗
Boston Scientific Corporation (NYSE: BSX) said it expects FARAPULSE Pulsed Field Ablation (PFA) System to get  
Via Benzinga
News headline image
Show Me The Money: Inside Ken Griffin's Citadel's Jaw-Dropping $7 Billion Return ↗
 
Via Benzinga
News headline image
This Analyst Selects Enovis As Top Pick For 2024: Spotlight On EMPOWR Revision Launch ↗
Needham analyst Mike Matson reiterated the Buy rating on Enovis Corporation (NYSE: ENOV), raising  
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.